Treatment of medically inoperable non-small-cell lung cancer with stereotactic body radiation therapy versus image-guided tumor ablation: Can interventional radiology compete?

Journal of Vascular and Interventional Radiology

Volumn 24, Issue 8, 2013, Pages 1139-1145

  Dupuy, Damian E ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHUS STENOSIS; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; IMAGE GUIDED RADIOTHERAPY; INOPERABLE CANCER; INTERMETHOD COMPARISON; INTERVENTIONAL RADIOLOGY; LUNG NON SMALL CELL CANCER; LUNG TOXICITY; OVERALL SURVIVAL; PNEUMOTHORAX; PRIORITY JOURNAL; RADIATION INJURY; REVIEW; STEREOTACTIC BODY RADIATION THERAPY; STEREOTACTIC RADIOSURGERY; TUMOR ABLATION;

ACOSOG; AMERICAN COLLEGE OF SURGEONS ONCOLOGY GROUP; IGTA; IMAGE-GUIDED TUMOR ABLATION; NATIONAL CANCER INSTITUTE; NCI; NON-SMALL-CELL LUNG CANCER; NSCLC; PET; POSITRON EMISSION TOMOGRAPHY; RADIATION THERAPY ONCOLOGY GROUP; RADIOFREQUENCY; RF; RTOG; SBRT; STEREOTACTIC BODY RADIATION THERAPY;

CARCINOMA, NON-SMALL-CELL LUNG; CATHETER ABLATION; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; PATIENT SELECTION; RADIOGRAPHY, INTERVENTIONAL; RADIOSURGERY; RISK FACTORS; TREATMENT OUTCOME;

EID: 84880758879     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2013.04.021     Document Type: Review

References (40)

1. American Cancer Society Cancer facts and figures 2012 2012 American Cancer Society Atlanta
2. P.B. Bach, L.D. Cramer, and J.L. Warren Racial differences in the treatment of early stage non-small cell lung cancer N Eng J Med 341 1999 1198 1205
3. E.D. Churchill, R.H. Sweet, L. Sutter, and J.G. Scannell The surgical management of carcinoma of the lung. A study of cases treated at the Massachusetts General Hospital from 1930-50 J Thorac Cardiovasc Surg 20 1950 349 365
4. R.J. Ginsberg, and L.V, Rubenstein for the Lung Cancer Study Group. Randomized trial of lobectomy vs. limited resection for TINO non-small cell lung cancer Ann Thorac Surg 60 1995 615 623
5. W.H. Warren, and L.P. Faber Segmentectomy versus lobectomy in patients with Stage I pulmonary carcinoma J Thorac Cardiovasc Surg 107 1994 1087 1094
6. R.J. Landreneau, D.J. Sugarbaker, and M.J. Mack Wedge resection versus lobectomy for stage I (T1NOMO) non-small cell lung cancer J Thorac Cardiovasc Surg 113 1997 691 700
7. J.I. Miller, and C.R. Hatcher Limited resection of bronchogenic carcinoma in the patient with marked impairment of pulmonary function Ann Thorac Surg 44 1987 340 343
8. S. Yendamuri, R. Sharma, and M. Demmy Temporal trends in outcomes following sublobar and lobar resections for small (≤ 2 cm) non-small cell lung cancers - a Surveillance Epidemiology End Results database analysis J Surg Res S0022-4804 2012 01920 01928
9. N.P. Rowell, and C.J. Williams Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review Thorax 56 2001 628 638
10. B.K. Chang, and R.D. Timmerman Stereotactic body radiation therapy: a comprehensive review Am J Clin Oncol 30 2007 637 644
11. D.E. Dupuy Image-guided thermal ablation of lung malignancies Radiology 260 2011 633 655
12. H. Pan, B.S. Rose, D.R. Simpson, L.K. Mell, A.J. Mundt, and J.D. Lawson Clinical practice patterns of lung stereotactic body radiation therapy in the United States: a secondary analysis Am J Clin Oncol 2013 10.1097/COC. 0b013e3182467db3
13. A.J. Fakiris, R.C. McGarry, and C.T. Yiannoutsos Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four years results of a prospective phase II study Int J Radiation Biol Phys 75 2009 677 682
14. P. Baumann, J. Nyman, and M. Hoyer Outcome in a prospective phase II trial of medically inoperable stage 1 non-small-cell lung cancer patients treated with stereotactic body radiotherapy J Clin Oncol 27 2009 3290 3296
15. F.J. Lagerwaard, C.J. Haasbeek, E.F. Smit, B.J. Slotman, and S. Senan Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer Int J Radiat Oncol Biol Phys 70 2008 685 692
16. R.C. McGarry, L. Papiez, M. Williams, T. Whitford, and R.D. Timmerman Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study Int J Radiat Oncol Biol Phys 63 2005 1010 1015
17. H. Onishi, T. Araki, and H. Shirato Stereotactic hypofractionated high-dose irradiation for stage I non-small cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multi-institutional study Cancer 101 2004 1623 1631
18. R. Timmerman, R. Paulus, and J. Galvin Stereotactic body radiation therapy for inoperable early stage lung cancer JAMA 303 2010 1070 1076
19. Y. Ohta, M. Oda, and J. Wu Can tumor size be a guide for limited surgical resection in patients with peripheral non-small cell lung cancer? Assessment from the point of view of nodal micrometastasis J Thorac Cardiovasc Surg 122 2001 900 906
20. R. Viney, M.J. Boyer, and M.T. King Randomized controlled trial of the role of positron emission tomography in the management of stage I and II non-small cell lung cancer J Clin Oncol 22 2004 2357 2362
21. N. Kothary, J.J. Heit, and J.D. Louie Safety and efficacy of percutaneous fiducial marker implantation for image-guided radiation therapy J Vasc Interv Radiol 20 2009 235 239
22. N. Bhagat, N. Fidelman, and J.C. Durack Complications associated with the percutaneous insertion of fiducial markers in the thorax Cardiovasc Intervent Radiol 33 2010 1186 1191
23. J.C. Hong, N.C. Eclov, and Y. Yu Migration of implanted markers for image-guided lung tumor stereotactic ablative radiotherapy J Appl Clin Med Phys 14 2013 4046
24. D.E. Dupuy, R. Zagoria, W. Akerley, W. Mayo-Smith, P. Kavanagh, and H. Safran Percutaneous RF ablation of malignancies in the lung AJR Am J Roentgenol 174 2000 57 59
25. T. Hiraki, H. Gobara, H. Mimura, Y. Matsui, S. Toyooka, and S. Kanazawa Percutaneous radiofrequency ablation of clinical stage I non-small cell lung cancer J Thorac Cardiovasc Surg 142 2011 24 30
26. C.J. Simon, D.E. Dupuy, and T.A. DiPetrillo Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients Radiology 243 2007 268 275
27. R. Lencioni, L. Crocetti, and R. Cioni Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study) Lancet Oncol 9 2008 621 628
28. M. Lanuti, A. Sharma, and S.R. Digumarthy Radiofrequency ablation for treatment of medically inoperable stage I non-small cell lung cancer J Thorac Cardiovasc Surg 137 2009 160 166
29. L. Huang, Y. Han, and J. Zhao Is radiofrequency thermal ablation a safe and effective procedure in the treatment of pulmonary malignancies? Eur J Cardiothorac Surg 39 2010 348 351
30. M.D. Beland, E.J. Wasser, W.W. Mayo-Smith, and D.E. Dupuy Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation Radiology 254 2010 301 307
31. A. Zemlyak, W.H. Moore, and T.V. Bilfinger Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer J Am Coll Surg 211 2010 68 72
32. M.C. Ambrogi, O. Fanucchi, and R. Cioni Long-term results of radiofrequency ablation treatment of stage I non-small cell lung cancer: a prospective intention-to-treat study J Thorac Oncol 6 2011 2044 2051
33. T.G. Simon, M.D. Beland, J.T. Machan, T. Dipetrillo, and D.E. Dupuy Charlson Comorbidity Index predicts patient outcome, in cases of inoperable non-small cell lung cancer treated with radiofrequency ablation Eur J Radiol 81 2012 4167 4172
34. E.S. Alexander, J.T. Machan, T. Ng, L.D. Breen, T.A. Dipetrillo, and D.E. Dupuy Cost and effectiveness of radiofrequency ablation versus limited surgical resection for stage I non-small-cell lung cancer in elderly patients: is less more? J Vasc Interv Radiol 24 2013 476 482
35. C.L. Brace, J.L. Hinshaw, P.F. Laeseke, L.A. Sampson, and F.T. Lee Jr Pulmonary thermal ablation: comparison of radiofrequency and microwave devices by using gross pathologic and CT findings in a swine model Radiology 251 2009 705 711
36. G.D. Dodd III, N.A. Dodd, A.C. Lanctot, and D.A. Glueck Effect of variation of portal venous blood flow on radiofrequency and microwave ablations in a blood-perfused bovine liver model Radiology 267 2013 129 136
37. M. Lanuti, A. Sharma, H. Willers, S.R. Digumarthy, D.J. Mathisen, and J.A. Shepard Radiofrequency ablation for stage I non-small cell lung cancer: management of locoregional recurrence Ann Thorac Surg 93 2012 921 927
38. J. Donington, M. Ferguson, and P. Mazzone Thoracic Oncology Network of American College of Chest Physicians; Workforce on Evidence-Based Surgery of Society of Thoracic Surgeons. American College of Chest Physicians and Society of Thoracic Surgeons consensus statement for evaluation and management for high-risk patients with stage I non-small cell lung cancer Chest 142 2012 1620 1635
39. T. Crabtree, V. Puri, and R. Timmerman Treatment of stage I lung cancer in high-risk and inoperable patients: comparison of prospective clinical trials using stereotactic body radiotherapy (RTOG 0236), sublobar resection (ACOSOG Z4032), and radiofrequency ablation (ACOSOG Z4033) J Thorac Cardiovasc Surg 145 2013 692 699
40. D.J. Sher, J.O. Wee, and R.S. Punglia Cost-effectiveness analysis of stereotactic body radiotherapy and radiofrequency ablation for medically inoperable, early-stage non-small cell lung cancer Int J Radiat Oncol Biol Phys 81 2011 e767 e774